News | February 23, 2026
Bavarian Nordic bags $22.5M Canadian vaccine order
The order will cover the manufacturing of bulk vaccine in 2026
The order will cover the manufacturing of bulk vaccine in 2026
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
Dr Adams’ lab recently uncovered a novel cellular detoxification pathway driving Cisplatin resistance in NSCLC
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe
Bocunebart works by blocking pituitary adenylate cyclase-activating polypeptide
The company’s consolidated revenues rose 17.5% year-on-year to Rs. 2,265 crore
Subscribe To Our Newsletter & Stay Updated
